Results 301 to 310 of about 280,441 (363)

Cardiovascular Benefits of Salvia miltiorrhiza (Danshen) Supplementation: Bioactive Constituents, Mechanisms, Clinical Evidence and Implications for Nutritional Care

Food Science &Nutrition, Volume 14, Issue 5, May 2026.
Salvia miltiorrhiza (Danshen) contains bioactive tanshinones, including tanshinone IIA, cryptotanshinone, and tanshinone I, that exert cardioprotective effects through coordinated modulation of vascular endothelial growth factor receptor (VEGFR), transforming growth factor beta 1 (TGF‐β1), transforming growth factor beta receptor (TGF‐βR), toll‐like ...
Akash Vikal, Rashmi Maurya, Preeti Patel, Balak Das Kurmi, William N. Setzer, Javad Sharifi‐Rad, Daniela Calina   +6 more
wiley   +1 more source

Coronary artery bypass grafting following Ross procedure in a patient with familial hypercholesterolemia. [PDF]

Glob Cardiol Sci Pract
Briscoe JB, Shirodkar S, Bradshaw A, Carvajal M, Lawton JS, Aziz H.   +5 more
europepmc   +1 more source

Outcomes of Drug‐Coated Balloon Versus Drug‐Eluting Stent for In‐Stent Restenosis and De‐Novo Lesions: A Meta‐Analysis of Randomized Controlled Trials

Health Science Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background and Aims Drug‐coated balloons (DCBs) and drug‐eluting stents (DESs) are commonly used in percutaneous coronary interventions (PCI), but their long‐term comparative effectiveness remains unclear. This meta‐analysis aimed to compare the clinical and angiographic outcomes of DCB versus DES in patients with in‐stent restenosis (ISR) and
Arman Soltani Moghadam, Sina Kazemian, Shayan Shojaei, Saman Soltani Moghadam, Reza Hosseini Dolama, Rasoul Ebrahimi, Fatemeh Ojaghi Shirmard, Seyed Morteza Ali Pourfaraji, Mohammad Sadeq Najafi, Sara Hobaby, Hamidreza Soleimani, Masih Tajdini, Behnam Tehrani, Dhaval Kolte, Islam Elgendy, Sandeep Basavarajaiah, Azeem Latib, Yasar Sattar, M. Chadi Alraies, Kaveh Hosseini   +19 more
wiley   +1 more source

Red Cell Distribution Width is Associated with Bleeding Complications after Coronary Artery Bypass Grafting. [PDF]

Interdiscip Cardiovasc Thorac Surg
Heimisdottir AA, Rabelo LG, Magnusdottir MM, Jeppsson A, Gudbjartsson T.   +4 more
europepmc   +1 more source

Beyond the 30-day metric: National trends and predictors of 90-day readmission after coronary artery bypass grafting. [PDF]

Am Heart J Plus
Ahmed U, Sohail M, Hussain HS, Valencia J, Manji AA, Khabbaz K, Schaefer MS, Mahmood F, Sharkey A, Matyal R.   +9 more
europepmc   +1 more source

Acellular Tissue Engineered Vessels as Coronary Artery Bypass Grafts. [PDF]

JACC Basic Transl Sci
Williams AR, Nash KM, Kirkton RD, Levitan GS, Daubert MA, Whitney SA, Naegeli KM, Benkert AR, McCartney SL, Prichard HL, Niklason LE, Kypson AP.   +11 more
europepmc   +1 more source

Complete Revascularization in Coronary Artery Bypass Grafting: Separating the Wheat from the Chaff. [PDF]

J Chest Surg
Hwang HY.
europepmc   +1 more source

Intraoperative High-Volume Diuresis During Off-Pump Coronary Artery Bypass Grafting: Risk Factors and Clinical Impact. [PDF]

J Clin Med
Hou Y, Luo F, Li S, Cai F, Ma J.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Coronary Artery Bypass

Circulation, 1973
From October 1969 through March 1972, 1,276 patients underwent coronary artery bypass at the Texas Heart Institute. Associated conditions included simultaneous valve replacement and resection or repair of ventricular aneurysms or ascending aortic aneurysms.
R J, Hall, J T, Dawson, D A, Cooley, G L, Hallman, F M, Sandiford, D C, Wukasch, E, Garcia   +6 more
openaire   +4 more sources